Navigation Links
MU researchers advance health communication for at-risk populations
Date:10/27/2008

COLUMBIA, Mo. Health Literacy Month, recognized in October, promotes the importance of ensuring access to understandable health information. According to the National Assessment of Adult Literacy, only 12 percent of adults have proficient health literacy - skills needed to manage their health. Improving health literacy for at-risk populations is the focus of an ongoing study at the University of Missouri Health Communication Research Center (HCRC). Recently, the National Cancer Institute (NCI) awarded an $8.6 million grant to HCRC, in partnership with Washington University in St. Louis, to advance health communication that will improve health literacy and health outcomes for at-risk populations.

The renewal grant will fund the continuation of Ozioma (which means "good news" in Ebu), a bi-weekly news service created by MU researchers that produces localized cancer-related news releases for black communities. The researchers analyzed the effectiveness of the news service and found that providing localized cancer news to black newspapers increased cancer news coverage and, therefore, prompted changes in readers' behaviors.

"Our goal is to build on the findings from the Ozioma study by advancing tailored communication and health public relations to improve health outcomes for at-risk and general populations," said Jon Stemmle, HCRC assistant director. "We will develop a news information bureau that will provide locally relevant and race-specific cancer news stories to minority newspapers in predominately minority markets throughout the United States."

The news service will provide health stories to 36 newspapers. According to the researchers, the objective is to develop a permanent news service for NCI that targets every minority newspaper service in the United States.

"Providing people with understandable health information is essential to improving their health literacy," said Glen T. Cameron, HCRC director and MU Maxine Wilson Gregory Chair in Journalism Research. "We hope to engage media in this process through our new news service, Informing Smart Health Decisions (I-SHD). Most press releases are general in form, created for the mass media audience. I-SHD is a cutting-edge approach to media relations that localizes a general release by region, state or community. We use local quotes, graphics and data to make the story more meaningful both for the local media and their audience."

The HCRC team consists of Cameron, Stemmle and Maria Len-Rios, assistant professor of strategic communication in the Missouri School of Journalism, and a team of HCRC graduate students. The project also will include members of the Health Communication Research Laboratory at Washington University in St. Louis.


'/>"/>

Contact: Emily Smith
SmithEA@missouri.edu
573-882-3346
University of Missouri-Columbia
Source:Eurekalert

Related medicine news :

1. Stanford researchers find culprit in aging muscles that heal poorly
2. UCLA researchers identify markers that may predict diabetes in still-healthy people
3. Mayo Clinic researchers discover new diagnostic test for detecting infection in prosthetic joints
4. Bipolar disorder relapses halved by Melbourne researchers
5. Cell that triggers symptoms in allergy attacks can also limit damage, Stanford researchers find
6. High and mighty: first common height gene identified by researchers behind obesity gene finding
7. Researchers estimate about 9 percent of US children age 8 to 15 meet criteria for having ADHD
8. Majority of 2.4 Million U.S. Children With ADHD Not Diagnosed or Consistently Treated, According to New Gold Standard Study by Cincinnati Childrens Researchers
9. Researchers develop long-lasting growth hormone
10. Jefferson immunology researchers halt lethal rabies infection in brain
11. Purdue researchers develop technology to detect cancer by scanning surface veins
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... ... , ... Are You Concerned About Mold In Your Home or Workplace? ... Companies in VA, MD and DC, recently completed its application for the new District ... in the district of Columbia is a good thing stated John Taylor, Owner of ...
(Date:12/2/2016)... ... December 02, 2016 , ... Lori G. Cohen and Sara ... speak at the American Conference Institute’s 21st Drug & Medical Device Litigation Conference ... Sponsor of the conference. , Cohen, who chairs the firm’s Pharmaceutical, Medical Device & ...
(Date:12/2/2016)... Los Angeles, CA (PRWEB) , ... December 02, 2016 , ... For over twenty-four years, ... a lien basis to help personal injury victims find high quality medical care. When ... the Los Angeles area. Fast forward to present day and the now ten-page directory ...
(Date:12/2/2016)... ... December 02, 2016 , ... FlexiSpot, ... of its 60-day free trial program for all of the company’s desktop riser ... a truly hassle free experience. , FlexiSpot’s unique desktop risers use an advanced ...
(Date:12/2/2016)... New York, NY (PRWEB) , ... December 02, 2016 , ... ... Through an exclusive interview with Mediaplanet, Dr. Murthy explains how he was inspired to ... “Early on I learned that medicine is about more than making diagnoses and prescribing ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... -- Seno Medical Instruments, Inc., the company pioneering the development ... the process of diagnosing breast cancer, today announced that ... surveillance and clinical follow-up study at the 2016 ... from December 6-10, 2016 at the Henry B. Gonzalez ... . Seno Medical Instruments will present two ...
(Date:12/5/2016)... and TAIPEI, Taiwan , Dec. ... months of treatment ropeginterferon alfa-2b showed non-inferiority to hydroxyurea (HU) ... a significantly better safety and tolerability profile of ropeginterferon alfa-2b ... from PROUD-PV and the ongoing long-term follow-up trial CONTINUATION-PV to ... PharmaEssentia intends to present this data to the FDA ...
(Date:12/4/2016)... 3, 2016 Sickle cell disease (SCD) is ... blood cells that get stuck in veins and block ... failure, and complications leading to death. Each year, approximately ... and most of them lack access to comprehensive care ... long-term therapy for SCD, a pill called hydroxyurea approved ...
Breaking Medicine Technology: